Data / Drug companies / Sterling Spa
Sterling Spa: 62 products in the FDA NDC directory, labeler code 64918
Sterling Spa (labeler code 64918) lists 62 products in the FDA National Drug Code Directory. By type: 62 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on April 22, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 64918
- Products in commercial distribution
- 62
- Packages
- 63
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- October 19, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 54 | 87.1% |
| Bulk ingredients for compounding | 8 | 12.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 62 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 57 | 91.9% |
| Inhalant | 5 | 8.1% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Orforglipron hemicalcium hydrate | 64918-5930 | Powder | Bulk ingredients | April 22, 2026 |
| Ensifentrine | 64918-5929 | Powder | Bulk ingredients | February 27, 2026 |
| Nilotinib trifluoroacetate | 64918-1942 | Powder | Bulk ingredients | January 24, 2024 |
| Medroxyprogesterone acetate | 64918-1941 | Powder | Bulk ingredients | January 15, 2024 |
| Norgestrel | 64918-1940 | Powder | Bulk ingredients | December 18, 2023 |
| Fluticasone furoate | 64918-1939 | Powder | Bulk ingredients | August 28, 2023 |
| Cabozantinib | 64918-1924 | Powder | Bulk ingredients | May 12, 2023 |
| Ruxolitinib | 64918-1902 | Powder | Bulk ingredients | March 8, 2023 |
| Vilanterol trifenatate | 64918-1921 | Powder | Bulk ingredients | June 4, 2022 |
| Umeclidinium bromide | 64918-1920 | Powder | Bulk ingredients | June 4, 2022 |
| Altrenogest | 64918-5931 | Powder | Bulk ingredients | June 1, 2022 |
| Vilanterol trifenatate | 64918-1919 | Powder | Bulk ingredients | January 4, 2022 |
| Umeclidinium bromide | 64918-1918 | Powder | Bulk ingredients | January 4, 2022 |
| Methylprednisolone suleptanate | 64918-1917 | Powder | Bulk ingredients | January 4, 2022 |
| Fluticasone furoate | 64918-1916 | Powder | Bulk ingredients | January 4, 2022 |
| Fluticasone furoate | 64918-1915 | Powder | Bulk ingredients | January 4, 2022 |
| Levonorgestrel acetate | 64918-1907 | Powder | Bulk ingredients | April 14, 2021 |
| Nomegestrol acetate | 64918-1004 | Powder | Bulk ingredients | January 1, 2020 |
| Mometasone furoate monohydrate | 64918-1912 | Inhalant | Bulk ingredients | November 13, 2019 |
| Fluticasone furoate | 64918-1910 | Inhalant | Bulk ingredients | November 13, 2019 |
| Etonogestrel | 64918-1906 | Powder | Bulk ingredients | November 13, 2019 |
| Dydrogesterone | 64918-1905 | Powder | Bulk ingredients | November 13, 2019 |
| Dutasteride | 64918-1904 | Powder | Bulk ingredients | November 13, 2019 |
| Drospirenone | 64918-1903 | Powder | Bulk ingredients | November 13, 2019 |
| Ciclesonide | 64918-1900 | Inhalant | Bulk ingredients | November 13, 2019 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.